TY - JOUR AU - Seaquist, E. R. AU - Goetz, F. C. AU - Rich, S. AU - Barbosa, J. PY - 1989 DA - 1989// TI - Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy JO - N Engl J Med VL - 320 UR - https://doi.org/10.1056/NEJM198905043201801 DO - 10.1056/NEJM198905043201801 ID - Seaquist1989 ER - TY - JOUR AU - Rizvi, S. AU - Raza, S. T. AU - Mahdi, F. PY - 2014 DA - 2014// TI - Association of genetic variants with diabetic nephropathy JO - World J Diabetes VL - 15 UR - https://doi.org/10.4239/wjd.v5.i6.809 DO - 10.4239/wjd.v5.i6.809 ID - Rizvi2014 ER - TY - JOUR AU - Deeb, S. S. AU - Fajas, L. AU - Nemoto, M. AU - Pihlajamäki, J. AU - Mykkänen, L. AU - Kuusisto, J. PY - 1998 DA - 1998// TI - A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity JO - Nat Genet VL - 20 UR - https://doi.org/10.1038/3099 DO - 10.1038/3099 ID - Deeb1998 ER - TY - JOUR AU - Luo, W. AU - Cao, J. AU - Li, J. AU - He, W. PY - 2008 DA - 2008// TI - Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress JO - Exp Gerontol VL - 43 UR - https://doi.org/10.1016/j.exger.2007.11.002 DO - 10.1016/j.exger.2007.11.002 ID - Luo2008 ER - TY - JOUR AU - Gouda, H. N. AU - Sagoo, G. S. AU - Harding, A. H. AU - Yates, J. AU - Sandhu, M. S. AU - Higgins, J. P. PY - 2010 DA - 2010// TI - The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis JO - Am J Epidemiol VL - 15 UR - https://doi.org/10.1093/aje/kwp450 DO - 10.1093/aje/kwp450 ID - Gouda2010 ER - TY - JOUR AU - Badal, S. S. AU - Danesh, F. R. PY - 2014 DA - 2014// TI - New insights into molecular mechanisms of diabetic kidney disease JO - Am J Kidney Dis VL - 63 UR - https://doi.org/10.1053/j.ajkd.2013.10.047 DO - 10.1053/j.ajkd.2013.10.047 ID - Badal2014 ER - TY - JOUR AU - Singh, A. K. AU - Kari, J. A. PY - 2013 DA - 2013// TI - Metabolic syndrome and chronic kidney disease JO - Curr Opin Nephrol Hypertens VL - 22 UR - https://doi.org/10.1097/MNH.0b013e32835dda78 DO - 10.1097/MNH.0b013e32835dda78 ID - Singh2013 ER - TY - JOUR AU - Sarafidis, P. A. AU - Georgianos, P. I. AU - Lasaridis, A. N. PY - 2011 DA - 2011// TI - PPAR-γ agonism for cardiovascular and renal protection JO - Cardiovasc Ther VL - 29 UR - https://doi.org/10.1111/j.1755-5922.2010.00222.x DO - 10.1111/j.1755-5922.2010.00222.x ID - Sarafidis2011 ER - TY - JOUR AU - Liu, L. AU - Zheng, T. AU - Wang, F. AU - Wang, N. AU - Song, Y. AU - Li, M. PY - 2010 DA - 2010// TI - Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc09-1258 DO - 10.2337/dc09-1258 ID - Liu2010 ER - TY - JOUR AU - Lapice, E. AU - Pinelli, M. AU - Riccardi, G. AU - Vaccaro, O. PY - 2010 DA - 2010// TI - Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients: comment on the study by Liu et al JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc10-0596 DO - 10.2337/dc10-0596 ID - Lapice2010 ER - TY - JOUR AU - Erdogan, M. AU - Karadeniz, M. AU - Eroglu, Z. AU - Tezcanli, B. AU - Selvi, N. AU - Yilmaz, C. PY - 2007 DA - 2007// TI - The relationship of the peroxisome proliferator-activated receptor gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy JO - Diabetes Res Clin Pract VL - 78 UR - https://doi.org/10.1016/j.diabres.2007.06.005 DO - 10.1016/j.diabres.2007.06.005 ID - Erdogan2007 ER - TY - JOUR AU - Pollex, R. L. AU - Mamakeesick, M. AU - Zinman, B. AU - Harris, S. B. AU - Hegele, R. A. AU - Hanley, A. J. PY - 2007 DA - 2007// TI - Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes JO - J Diabetes Complications VL - 21 UR - https://doi.org/10.1016/j.jdiacomp.2006.02.006 DO - 10.1016/j.jdiacomp.2006.02.006 ID - Pollex2007 ER - TY - JOUR AU - Caramori, M. L. AU - Canani, L. H. AU - Costa, L. A. AU - Gross, J. L. PY - 2003 DA - 2003// TI - The human peroxisome proliferatoractivated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes JO - Diabetes VL - 52 UR - https://doi.org/10.2337/diabetes.52.12.3010 DO - 10.2337/diabetes.52.12.3010 ID - Caramori2003 ER - TY - JOUR AU - Herrmann, S. M. AU - Ringel, J. AU - Wang, J. G. AU - Staessen, J. A. AU - Brand, E. PY - 2002 DA - 2002// TI - Berlin Diabetes Mellitus (BeDiaM) Study. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: the Berlin diabetes mellitus (BeDiaM) study JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.8.2653 DO - 10.2337/diabetes.51.8.2653 ID - Herrmann2002 ER - TY - JOUR AU - Cosmo, S. AU - Prudente, S. AU - Lamacchia, O. AU - Lapice, E. AU - Morini, E. AU - Paola, R. PY - 2011 DA - 2011// TI - PPAR {gamma} 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case–control studies JO - Nephrol Dial Transplant VL - 26 UR - https://doi.org/10.1093/ndt/gfr187 DO - 10.1093/ndt/gfr187 ID - Cosmo2011 ER - TY - JOUR AU - Zhang, H. AU - Zhu, S. AU - Chen, J. AU - Tang, Y. AU - Hu, H. AU - Mohan, V. PY - 2012 DA - 2012// TI - Peroxisome proliferator–activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc11-2142 DO - 10.2337/dc11-2142 ID - Zhang2012 ER - TY - JOUR AU - Jorsal, A. AU - Tarnow, L. AU - Lajer, M. AU - Ek, J. AU - Hansen, T. AU - Pedersen, O. PY - 2008 DA - 2008// TI - The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy JO - Mol Genet Metab VL - 94 UR - https://doi.org/10.1016/j.ymgme.2008.03.014 DO - 10.1016/j.ymgme.2008.03.014 ID - Jorsal2008 ER - TY - JOUR AU - Lapice, E. AU - Cocozza, S. AU - Riccardi, G. AU - Vaccaro, O. PY - 2013 DA - 2013// TI - Comment on: Zhang et al. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc12-1993 DO - 10.2337/dc12-1993 ID - Lapice2013 ER - TY - JOUR AU - Williams, P. AU - Pendyala, L. AU - Superko, R. PY - 2011 DA - 2011// TI - Survival bias and drug interaction can attenuate cross sectional case–control comparisons of genes with health outcomes: an example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease JO - BMC Med Genet VL - 12 UR - https://doi.org/10.1186/1471-2350-12-42 DO - 10.1186/1471-2350-12-42 ID - Williams2011 ER - TY - JOUR AU - Cosmo, S. AU - Motterlini, N. AU - Prudente, S. AU - Pellegrini, F. AU - Trevisan, R. AU - Bossi, A. PY - 2009 DA - 2009// TI - BENEDICT Study Group. Impact of the PPARγ2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT JO - Diabetes VL - 58 UR - https://doi.org/10.2337/db09-0407 DO - 10.2337/db09-0407 ID - Cosmo2009 ER - TY - JOUR AU - Levey, A. S. AU - Stevens, L. A. AU - Schmid, C. H. AU - Zhang, Y. L. AU - Castro, A. F. AU - Feldman, H. I. PY - 2009 DA - 2009// TI - CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-9-200905050-00006 DO - 10.7326/0003-4819-150-9-200905050-00006 ID - Levey2009 ER - TY - JOUR AU - August, P. AU - Hardison, R. M. AU - Hage, F. G. AU - Marroquin, O. C. AU - McGill, J. B. AU - Rosenberg, Y. PY - 2014 DA - 2014// TI - Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study JO - Clin J Am Soc Nephrol VL - 9 UR - https://doi.org/10.2215/CJN.12281211 DO - 10.2215/CJN.12281211 ID - August2014 ER - TY - JOUR AU - Stevens, L. A. AU - Greene, T. AU - Levey, A. S. PY - 2006 DA - 2006// TI - Surrogate end points for clinical trials of kidney disease progression JO - Clin J Am Soc Nephrol VL - 1 UR - https://doi.org/10.2215/CJN.00600206 DO - 10.2215/CJN.00600206 ID - Stevens2006 ER - TY - JOUR AU - Ahmadian, M. AU - Suh, J. M. AU - Hah, N. AU - Liddle, C. AU - Atkins, A. R. AU - Downes, M. PY - 2013 DA - 2013// TI - PPARγ signaling and metabolism: the good, the bad and the future JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3159 DO - 10.1038/nm.3159 ID - Ahmadian2013 ER - TY - JOUR AU - Yang, J. AU - Zhou, Y. AU - Guan, Y. PY - 2012 DA - 2012// TI - PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases JO - Curr Opin Nephrol Hypertens VL - 21 UR - https://doi.org/10.1097/MNH.0b013e32834de526 DO - 10.1097/MNH.0b013e32834de526 ID - Yang2012 ER - TY - JOUR AU - Chung, B. H. AU - Lim, S. W. AU - Ahn, K. O. AU - Sugawara, A. AU - Ito, S. AU - Choi, B. S. PY - 2005 DA - 2005// TI - Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases JO - Nephrology VL - 10 UR - https://doi.org/10.1111/j.1440-1797.2005.00456.x DO - 10.1111/j.1440-1797.2005.00456.x ID - Chung2005 ER - TY - JOUR AU - Jia, Z. AU - Sun, Y. AU - Yang, G. AU - Zhang, A. AU - Huang, S. AU - Heiney, K. M. PY - 2014 DA - 2014// TI - New Insights into the PPAR γ agonists for the treatment of diabetic nephropathy JO - PPAR Res VL - 2014 ID - Jia2014 ER - TY - JOUR AU - Ochodnicky, P. AU - Mesarosova, L. AU - Cernecka, H. AU - Klimas, J. AU - Krenek, P. AU - Goris, M. PY - 2014 DA - 2014// TI - Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat JO - Eur J Pharmacol VL - 730 UR - https://doi.org/10.1016/j.ejphar.2014.02.023 DO - 10.1016/j.ejphar.2014.02.023 ID - Ochodnicky2014 ER -